McKesson Corp (MCK)

8,870.63 0.00 (0.00%)
Close MXN Disclaimer

McKesson Corp Company Profile

Equity Type
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment offers distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Contact Information
Irving,75039 United States
972 446 4800
Top Executives
Kenneth E. Washington 61 2019 Independent Director
Donald R. Knauss 71 2014 Independent Chairman of the Board
Brian S. Tyler 55 2012 CEO & Director
Bradley E. Lerman 65 2018 Independent Director
Susan R. Salka 57 2014 Independent Director
Dominic J. Caruso 64 2018 Independent Director
Maria N. Martinez 65 2019 Independent Director
Linda Provie Mantia 53 2020 Independent Director
Kathleen Wilson-Thompson 64 2022 Independent Director
James Hall Hinton 63 2022 Independent Director
Richard H. Carmona 72 2021 Independent Director
W. Roy Dunbar 63 2022 Independent Director
Kevin M. Ozan 61 2024 Independent Director
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles